Watch Ticker

Galecto, Inc. Common Stock

Go to Galecto, Inc. Common Stock Website

$3.26

-0.13 (-3.69%)

Live

Previous Close

$3.4

Day Range

$3.3581 - $3.4

Previous Day Range

$3.3456 - $3.55

Market Cap

$4.5 million USD

Day Vol.

58549

Previous Day Vol.

103032

Currency

USD

Primary Exchange

Nasdaq

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of gale...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Galecto to Participate in Upcoming Investor Conferences

Galecto, a clinical-stage biotechnology company, announced its participation in upcoming investor conferences, including the Oppenheimer 35th Annual Healthcare Life Sciences Conference, Leerink Partners Global Healthcare Conference, and 37th Annual ROTH Conference.

Related tickers: GLTO.

Read Full Article

N/A - Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines

Galecto is focusing its pipeline on cancer and liver disease, leveraging its existing clinical-stage asset GB1211. The company has also acquired the global rights to BRM-1420, a novel dual inhibitor for multiple genetic subsets of acute myeloid leukemia (AML), from Bridge Medicines.

Related tickers: GLTO.

Read Full Article

Trending Tickers

Please sign in to view